Alaunos Therapeutics (TCRT) EBITDA (2009 - 2026)
Alaunos Therapeutics (TCRT) recorded EBITDA of -$943,000 in Q2 2026, compared with -$1.04 million a year earlier.
Analysis
Alaunos Therapeutics (TCRT) EBITDA (2009 - 2026) Analysis & Trends
On a TTM basis, Alaunos Therapeutics' EBITDA came in at -$4.03 million as of Jun 30, 2026; for FY2025, it was -$4.22 million.
- Across earlier years, EBITDA came in at -$4.81 million in FY2024, -$31.95 million in FY2023, -$32.31 million in FY2022 and -$74.95 million in FY2021.
- Quarterly EBITDA has ranged from -$21.62 million in Q3 2021 to -$756,000 in Q4 2024 over the past five years.
- Per Business Quant, the preceding three quarters came in at -$1 million (Q1 2026), -$900,000 (Q4 2025) and -$1.19 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Alaunos Therapeutics | 2.39 Mn | -1.41 Mn | - | -943,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -943,000.00 |
| Mar 31, 2026 | -1.00 Mn |
| Dec 31, 2025 | -900,000.00 |
| Sep 30, 2025 | -1.19 Mn |
| Jun 30, 2025 | -1.04 Mn |
| Mar 31, 2025 | -1.09 Mn |
| Dec 31, 2024 | -756,000.00 |
| Sep 30, 2024 | -1.15 Mn |
| Jun 30, 2024 | -1.17 Mn |
| Mar 31, 2024 | -1.74 Mn |
| Dec 31, 2023 | -7.71 Mn |
| Sep 30, 2023 | -7.99 Mn |
| Jun 30, 2023 | -7.28 Mn |
| Mar 31, 2023 | -8.98 Mn |
| Dec 31, 2022 | -7.79 Mn |
| Sep 30, 2022 | -7.57 Mn |
| Jun 30, 2022 | -8.55 Mn |
| Mar 31, 2022 | -8.40 Mn |
| Dec 31, 2021 | -10.34 Mn |
| Sep 30, 2021 | -21.62 Mn |
API Access
Alaunos Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=TCRT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "TCRT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=TCRT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();